-
CRF1 and CRF2 antagonists disclosed in Neurocrine Biosciences patent
10 Jul 2025 20:51 GMT
Endocrine/;metabolic
Neurocrine Biosciences Inc. has divulged cyclic peptides … hypertension, among others.
BioWorld Science Endocrine/;metabolic Patents
-
Analyst Expectations For Neurocrine Biosciences's Future
02 Jun 2025 21:08 GMT
… recent developments related to Neurocrine Biosciences. This information offers … on Neurocrine Biosciences analyst ratings.
Discovering Neurocrine Biosciences: A Closer Look
Neurocrine Biosciences … treatment of neurological and endocrine-related diseases and …
-
Neurocrine Biosciences To Present Wide-Ranging One-Year Data From Phase 3 Cahtalysttm Pediatric Study At Pediatric Endocrine Society 2025 Annual Meeting
16 May 2025 14:34 GMT
… be presented at the Pediatric Endocrine Society (PES) 2025 … Prescribing Information .
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences is a leading neuroscience … SCIENCE are registered trademarks of Neurocrine Biosciences, Inc. CRENESSITY, CAHtalyst …
-
What to Expect from Neurocrine Biosciences's Earnings
02 May 2025 21:19 GMT
… insights regarding Neurocrine Biosciences.
The consensus rating for Neurocrine Biosciences is Buy, … metrics.
Discovering Neurocrine Biosciences: A Closer Look
Neurocrine Biosciences Inc engages … treatment of neurological and endocrine-related diseases and …
-
Endocrinolgoy Month in Review: May 2025
05 Jun 2025 00:13 GMT
… the obesity space.
In pediatric endocrinology, crinecerfont showed promise in … important updates in endocrinology from May 2025.
Endocrinology Pipeline and Regulatory … Analysis
On May 8, 2025, Neurocrine Biosciences announced exploratory Phase 3 CAHtalyst …
-
Deep Dive Into Neurocrine Biosciences Stock: Analyst Perspectives (14 Ratings)
26 Mar 2025 14:53 GMT
… Neurocrine Biosciences analyst ratings.
All You Need to Know About Neurocrine Biosciences
Neurocrine Biosciences … treatment of neurological and endocrine-related diseases and … to treat uterine fibroids.
Neurocrine Biosciences: Delving into Financials
…
-
Neurocrine Biosciences Reports Mixed Q4
07 Feb 2025 15:35 GMT
… estimates.
Neurological therapeutics specialist Neurocrine Biosciences (NBIX -13.88% … and administrative expenses
Understanding Neurocrine Biosciences
Neurocrine Biosciences is a biotechnology company … for neurological and endocrine-related diseases. The …
-
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2024 Earnings Call Transcript
07 Feb 2025 13:32 GMT
… highly engaged with the endocrinology community, conducting extensive educational … in from community endocrinologists, from endocrinologists that are part … Goodbye.
Follow Neurocrine Biosciences Inc (NASDAQ:NBIX) Follow Neurocrine Biosciences Inc (NASDAQ: …
-
What Analysts Are Saying About Neurocrine Biosciences Stock
20 Dec 2024 19:33 GMT
… on Neurocrine Biosciences analyst ratings.
Discovering Neurocrine Biosciences: A Closer Look
Neurocrine Biosciences … central nervous system and endocrine-related categories. The … syndrome.
Financial Milestones: Neurocrine Biosciences's Journey
Market …
-
Crinecerfont for Congenital Adrenal Hyperplasia Now Commercially Available, Neurocrine Biosciences Announces
20 Dec 2024 19:57 GMT
… older with the chronic endocrine disorder.
Crinecerfont directly reduces … , MD, PhD
Source: Neurocrine Biosciences announces commercial availability of CRENESSITY … adrenal hyperplasia. News release. Neurocrine Biosciences. December 20, 2024. Accessed …
About
© 1995-2025